iiinova — where your digital self keeps evolving

Reposted by Access to Meds | Public Citizen

Sarah Karlin-Smith @sarahkarlin-smith.bsky.social · 01/10/2026

Trump exempted nearly all pharma companies from one of his plans to cut drug prices in Medicare so expected savings dropped from nearly $12 billion to about $440 million. www.citizen.org/news/finaliz...

citizen.org

Finalized GLOBE Part B Model Is Full of Holes - Public Citizen

WASHINGTON, D.C. – The Centers for Medicare & Medicaid Services released its finalized GLOBE Medicare Part B drug price model…

041

Reposted by Access to Meds | Public Citizen

Sarah Karlin-Smith @sarahkarlin-smith.bsky.social · 31/08/2026

Trump is expected to announce more "most favored nation" drug pricing deals today. It has been almost a year since Trump first started rolling out these deals and he has almost nothing to show for it. New deals are a distraction from the administration’s failed plan to lower U.S. drug prices.

citizen.org

Trump’s Drug Pricing Deals Are a Farce - Public Citizen

WASHINGTON, D.C. – President Donald Trump is expected to announce more most-favored nation (MFN) drug pricing deals with additional pharmaceutical…

053

Reposted by Access to Meds | Public Citizen

The Washington Post @washingtonpost.com · 31/08/2026

The Trump administration is working to cut global health funding to developing nations by tens of billions of dollars by 2030, according to a new analysis of the secretive agreements U.S. officials have pursued with more than a dozen governments to date.

washingtonpost.com

Trump’s deals in Africa could cut U.S. health aid by more than half, analysis shows

The planned reductions — targeting programs that combat the spread of deadly diseases — coincide with an administration push to make developing nations spend more.

42620

Access to Meds | Public Citizen @pcmedsaccess.bsky.social · 31/08/2026

Public Citizen and @pih.org warn of cuts under Trump’s global health deals and a widening gap between Congressional funding and planned support for countries: www.citizen.org/news/trumps-.... PC’s FOIA requests also revealed 6 new health agreement texts: www.citizen.org/article/u-s-...

citizen.org

Trump’s Agreements with African Nations Slash Health Funding, New Documents Show - Public Citizen

WASHINGTON, D.C. – The Trump Administration is planning to radically reduce health funding for 18 low-income countries, a new report…

020

Reposted by Access to Meds | Public Citizen

Sarah Karlin-Smith @sarahkarlin-smith.bsky.social · 20/08/2026

If the consumer drug pricing index has seen unprecedented drops, Trump should get almost none of the credit. Few of Trump’s most-favored-nation (MFN) policies to reduce drug prices have even taken effect, the analysis explains, nor would many of his policies be trackable in the index. #healthpolicy

citizen.org

Four Reasons Trump’s Drug Pricing Claims Are Bogus - Public Citizen

The consumer pricing index’s measure of prescription drug pricing (CPI-Rx) fell by 3.1 percent over the 12 months ending in…

046

Reposted by Access to Meds | Public Citizen

Sarah Karlin-Smith @sarahkarlin-smith.bsky.social · 06/08/2026

New Public Citizen investigation: A little-known change to Medicare drug price negotiation rules may cost taxpayers billions of dollars and generate a windfall for AbbVie by excluding its pancreatic insufficiency drug Creon from negotiation for an extra seven years. #healthpolicy

citizen.org

Medicare Quietly Gifted AbbVie’s Blockbuster Drug Seven Extra Years Before Price Negotiations - Public Citizen

Key Takeaways: AbbVie’s Creon appeared to meet all the qualifications for selection to Medicare’s Drug Price Negotiation Program (MDPNP) in…

112

Reposted by Access to Meds | Public Citizen

Global Trade Watch @pcgtw.bsky.social · 26/06/2026

The Trump admin has signed data-sharing agreements about global health with more than 30 countries, refusing to make them public until at least 2027. We need transparency BEFORE a deal is signed, not years after.

101

Access to Meds | Public Citizen @pcmedsaccess.bsky.social · 18/06/2026

Thanks @fastlerner.bsky.social and @annamaria.bsky.social for speaking with us about the Trump admin’s unprecedented demands for data access in exchange for global health funding. Our new analysis of the few publicly-available health agreements: www.citizen.org/wp-content/u...

citizen.org

043

Access to Meds | Public Citizen @pcmedsaccess.bsky.social · 15/04/2026

Public Citizen’s Peter Maybarduk told ICIJ that pharma created a system of rules to protect drugmakers and ensure wealthy governments protect them “There is a whole architecture underpinning Keytruda and every patented drug where the US government and Europe go to bat for the industry and its rules”

053

Reposted by Access to Meds | Public Citizen

ICIJ @icij.org · 13/04/2026

#CancerCalculus: An ICIJ-led collaboration with 47 media partners in 37 countries reveals how Merck & Co. keeps the price of its lifesaving cancer drug Keytruda sky-high, locking out patients and squeezing health care systems worldwide. www.icij.org/investigatio...

47951

Reposted by Access to Meds | Public Citizen

Global Trade Watch @pcgtw.bsky.social · 26/03/2026

Holding HIV treatment hostage to extract mineral deals is indefensible. More than a million Zambians rely on this aid. This administration always finds a new low. www.nytimes.com/2026/03/16/h...

nytimes.com

U.S. Considers Withholding H.I.V. Aid Unless Zambia Expands Minerals Access

275

Access to Meds | Public Citizen @pcmedsaccess.bsky.social · 26/03/2026

Transparency and obligations that support broad access to medical tools are non-negotiable in pandemic prevention, preparedness and response. Public Citizen, @Saludporderecho.bsky.social, and @hai-org.bsky.social are calling on the EU and others to step up: saludporderecho.org/mpox-y-acces...

saludporderecho.org

Mpox y acceso global: las mismas barreras de siempre

La mpox ha vuelto a situar en primer plano los desafíos pendientes en la respuesta global a las crisis sanitarias. Es una enfermedad infecciosa que en pocos años ha provocado

000

Reposted by Access to Meds | Public Citizen

Health Action International @hai-org.bsky.social · 23/03/2026

In a statement on behalf of HAI, @publiccitizen.bsky.social & @saludporderecho.bsky.social to 6th IGWG meeting on the #PandemicAgreement, we warned that a vague text with no binding obligations, workable schemes or enforceable commitments cannot be considered a success: haiweb.org/media-resour...

haiweb.org

Statement to the 6th IGWG on WHO Pandemic Agreement - Health Action International

This statement to the 6th meeting of the IGWG on WHO Pandemic Agreement was delivered on behalf of HAI, Salud por Derecho and Public Citizen

023

Reposted by Access to Meds | Public Citizen

Peter Maybarduk @maybarduk.bsky.social · 10/03/2026

Pfizer’s CEO said Pharma may “stop supplying” countries that don’t pay more in response to Trump’s threats & pressure campaign. This would be a classic “working failure,” grounds for compulsory license in every patent law. Drugmakers that threaten supply lose monopoly privileges. We wrote Bourla:

121

Reposted by Access to Meds | Public Citizen

Sarah Karlin-Smith @sarahkarlin-smith.bsky.social · 09/03/2026

Americans aren’t going bankrupt from their cancer treatment because Europeans are getting the same treatment for less. They are going broke so pharma CEOs can get their multi-million dollar paydays, and they are going broke so pharma can enrich shareholders w/ billions in dividends & stock buybacks.

citizen.org

Pfizer Cannot Hold Prescription Drugs Hostage from European Nations, Must Take Accountability for High Prices - Public Citizen

WASHINGTON, D.C. — Today, Public Citizen sent a letter demanding Pfizer commit to making its medicines reliably accessible everywhere after its CEO, Albert Bourla, told…

13415

Reposted by Access to Meds | Public Citizen

Peter Maybarduk @maybarduk.bsky.social · 25/02/2026

The White House still has not published any of its deals with drugmakers, making its claims to have lowered prices very difficult to believe. But we know for a fact Trump & GOP gave pharma an $8+ billion payout out of pockets of taxpayers & cancer patients via the Big Ugly Bill.

citizen.org

Don’t Buy Trump’s SOTU Claims on Drug Prices - Public Citizen

In his State of the Union speech, President Trump is expected to tout progress from his administration on lowering drug prices for Americans, but the rhetoric will not match the reality. Here are the ...

011

Reposted by Access to Meds | Public Citizen

Global Health Council @globalhealthorg.bsky.social · 19/02/2026

A new data tool for advocates: The Health Security Policy Academy has released its U.S. Global Health Spending Watch dashboard, which tracks how the U.S. government obligates and spends #GlobalHealth funds. Explore the dashboard and accompanying blog:

globalhealthwatch.org

U.S. Global Health Spending Watch.

The data are public. We just make them usable.

001

Reposted by Access to Meds | Public Citizen

Global Trade Watch @pcgtw.bsky.social · 19/02/2026

The Trump administration is using U.S. trade power and extreme tariffs to bully other countries into binding agreements that undermine affordable and readily available access to medicines. Experts from around the world offer an alternate vision:

Teal background, highlighted quote: "Pro-corporate, pro-monopoly models reinforced by the current trade order and exploited by the powerful are failing the world. Health must be a guarantee, not a bargaining chip."

Blue background with caption: Over 100 organizations around the world detail principles for trade that ensure access to medicines."

12616

Access to Meds | Public Citizen @pcmedsaccess.bsky.social · 13/02/2026

Canada will get <$100 weight loss drugs, while Americans still struggle with the world’s highest prices. We asked HHS to allow generic competition, overcoming the drugmakers’ patent barriers to improve access to expensive GLP-1s for weight loss, diabetes, and other conditions.

citizen.org

New HHS petition Calls on the Trump Administration to Authorize Affordable Generic GLP-1 Drugs for Americans - Public Citizen

WASHINGTON, D.C. — Today, Public Citizen filed a petition requesting that the United States Department of Health and Human Services…

000

Reposted by Access to Meds | Public Citizen

Resilience Action Network Africa @ranafrica.org · 10/12/2025

📢 Ranafrica.org, @publiccitizen.bsky.social, People's Health Movement Kenya, and nearly 50 CSOs call on African leaders to demand equity and sovereignty rather than one-sided terms in new bilateral health agreements with the U.S. Read the letter. ⬇️ www.ranafrica.org/news/african...

032

Reposted by Access to Meds | Public Citizen

Salud por Derecho @saludporderecho.bsky.social · 03/12/2025

📢Junto a @publiccitizen.bsky.social, @hai-org.bsky.social y otras 26 organizaciones pedimos a HERA (UE) más transparencia en el acuerdo con Bavarian Nordic para la compra de 8 millones de dosis de la vacuna mpox/smallpox Aquí más info👉 www.citizen.org/article/civi...

citizen.org

Civil Society Letter to EU HERA on Mpox/Smallpox Vaccine Procurement and Global Access - Public Citizen

Dear Commissioner Lahbib and Director-General Fink-Hooijer, As organisations concerned with equitable access to health products in the European Union and…

122

Reposted by Access to Meds | Public Citizen

Global Trade Watch @pcgtw.bsky.social · 02/12/2025

Under threat of higher tariffs, the UK has agreed to give more money to Big Pharma, which will do NOTHING to lower the cost of medicines in the U.S. More evidence that Trump’s tariffs are about helping his CEO buds, not working people.

122

Access to Meds | Public Citizen @pcmedsaccess.bsky.social · 26/11/2025

Lenacapavir could sharply cut new HIV infections. But only if people can actually get it. Watch this brief video from @maybarduk.bsky.social on how monopoly power is limiting access, and why World AIDS Day is the moment to demand change. www.instagram.com/p/DRh2CUIjl-Z/

031

Access to Meds | Public Citizen @pcmedsaccess.bsky.social · 21/11/2025

Instead of giving handouts to Big Pharma at patients’ expense, Congress should work to lower drug costs, including by expanding price negotiations to allow all patients to access lower negotiated prices, even if they don’t have Medicare. Read more here: www.citizen.org/news/hundred...

citizen.org

Hundreds of Lobbyists Try to Clawback Medicare Drug Price Negotiations, Win Trump’s Favor - Public Citizen

WASHINGTON, D.C. — Big Pharma and its allies have taken corporate influence in Washington to new heights, hiring more than…

000

Access to Meds | Public Citizen @pcmedsaccess.bsky.social · 21/11/2025

Does it pay? According to the CBO, one of the bills – the now-passed ORPHAN Cures Act – returns over $8 billion to pharma’s pockets. The proposed EPIC Act (that Trump essentially endorsed in an April EO) would return tens of billions more.

100

Access to Meds | Public Citizen @pcmedsaccess.bsky.social · 21/11/2025

Big Pharma and its allies hired over 500 lobbyists this year to push 3 bills to erode a landmark reform that lets Medicare negotiate lower drug prices, according to our new report. Their lobbyist hires outnumbered public interest advocates fighting the bad bills by 20-to-1.

100

Reposted by Access to Meds | Public Citizen

Global Trade Watch @pcgtw.bsky.social · 04/11/2025

Trade agreements must not stand in the way of health and access to medicines. USMCA must be revised to remove extreme intellectual property provisions that keep medicine prices high, discourage competition, and ultimately impede access to medicine.

163

Reposted by Access to Meds | Public Citizen

Public Citizen @publiccitizen.bsky.social · 25/09/2025

Thanks to health leaders Emily Bass, Mitchell Warren, Asia Russell, Amanda Banda, and Isata Dumbuya. And to our event co-hosts UNAIDS, Health GAP, People's Medicines Alliance, UAEM, Treatment Action Group, RESULTS, and Partners In Health.

0226

Reposted by Access to Meds | Public Citizen

Public Citizen @publiccitizen.bsky.social · 25/09/2025

We had a critical discussion about continuing the fight to bring medicines to all, with the first step being bringing that breakthrough — at that price — to the world. Thanks to UNAIDS' Winnie Byanyima and Unitaid's Tenu Avafia for joining us today and for your leadership.

1214

Reposted by Access to Meds | Public Citizen

Public Citizen @publiccitizen.bsky.social · 25/09/2025

This week, the world learned that a new HIV prevention drug will be available for $40/year in 120 countries by 2027. Yet millions of people in countries with growing HIV crises still are left out. Today, health groups came together to support access for everyone, everywhere.

438290